(2-Aminopyridin-3-yl)boronic acid

Catalog No.: 
ACBTAM876
CAS No.: 
1204112-62-8
Molecular Formula: 
C5H7BN2O2
Molecular Weight: 
137.93
(2-Aminopyridin-3-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$62.00In stockInquiry
250mg98%$104.00In stockIn stock
1g98%$189.00In stockIn stock
5g98%$551.00In stockInquiry
25g98%$2204.00In stockInquiry
100g98%$7419.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2-Aminopyridin-3-yl)boronic acid
IUPAC Name(2-aminopyridin-3-yl)boronic acid
MDL No.MFCD11865292
Molecular FormulaC5H7BN2O2
Molecular Weight137.93
SMILESNC1=NC=CC=C1B(O)O
InChI KeyYKFFTFAARIPGPK-UHFFFAOYSA-N
Synonym2-aMinopyridin-3-ylboronic acid;2-AMINOPYRIDIN-3-YLBORONIC ACID HCl;2-Aminopyridine-3-boronic acid·2HCl2;2-AMinopyridine-3-boronic acid;Boronic acid, B-(2-amino-3-pyridinyl)-;B-(2-Amino-3-pyridinyl)boronic acid;B-(2-Aminopyridin-3-yl)boronic acid;(2-aminopyridin-3-yl)boronic acid - [A17426]
CAS No.1204112-62-8
PubChem CID53441670

Synthetic Route by SureRoute

1. ACBTAM876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. ACMAZP706 route compound structure diagram
    ACMAZP706381248-04-0In Stock
  4. Then
  5. ACBTAM876 route product structure diagram
    ACBTAM8761204112-62-8In Stock
Inquiry

2. ACBTAM876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBTAM876 route product structure diagram
    ACBTAM8761204112-62-8In Stock
Inquiry

3. ACBTAM876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBTAM876 route product structure diagram
    ACBTAM8761204112-62-8In Stock
Inquiry

Comments (0)